ZITELLA, Andrea
ZITELLA, Andrea
68Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC): a prospective single-centre study in patients eligible for salvage therapy
2020-01-01 Deandreis D.; Guarneri A.; Ceci F.; Lillaz B.; Bartoncini S.; Oderda M.; Nicolotti D.G.; Pilati E.; Passera R.; Zitella A.; Bello M.; Parise R.; Carlevato R.; Ricardi U.; Gontero P.
[Neuroendocrine bladder cancer: oncological emergency?]
2008-01-01 Fiorito, C; Lucca, I; Oderda, M; Mondino, P; Berta, G; Cattaneo, E A; Valentino, F; Zitella, A; Pacchioni, D
A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
2015-01-01 Gontero, Paolo; Marra, Giancarlo; Soria, Francesco; Oderda, Marco; Zitella, Andrea; Baratta, Francesca; Chiorino, Giovanna; Gregnanin, Ilaria; Daniele, Lorenzo; Cattel, Luigi; Frea, Bruno; Brusa, Paola
Association Study between Polymorphisms in DNA Methylation-Related Genes and Testicular Germ Cell Tumor Risk
2022-01-01 Grasso, Chiara; Popovic, Maja; Isaevska, Elena; Lazzarato, Fulvio; Fiano, Valentina; Zugna, Daniela; Pluta, John; Weathers, Benita; D'Andrea, Kurt; Almstrup, Kristian; Anson-Cartwright, Lynn; Bishop, D Timothy; Chanock, Stephen J; Chen, Chu; Cortessis, Victoria K; Dalgaard, Marlene D; Daneshmand, Siamak; Ferlin, Alberto; Foresta, Carlo; Frone, Megan N; Gamulin, Marija; Gietema, Jourik A; Greene, Mark H; Grotmol, Tom; Hamilton, Robert J; Haugen, Trine B; Hauser, Russ; Karlsson, Robert; Kiemeney, Lambertus A; Lessel, Davor; Lista, Patrizia; Lothe, Ragnhild A; Loveday, Chey; Meijer, Coby; Nead, Kevin T; Nsengimana, Jérémie; Skotheim, Rolf I; Turnbull, Clare; Vaughn, David J; Wiklund, Fredrik; Zheng, Tongzhang; Zitella, Andrea; Schwartz, Stephen M; McGlynn, Katherine A; Kanetsky, Peter A; Nathanson, Katherine L; Richiardi, Lorenzo
Chromogranine A serum levels in patients affected by prostate cancer and benign prostate hypertrophy: comparison between two different commercial kits
2005-01-01 Bosio A; Berruti A; Zitella A; Mengozzi G; Destefanis P; Bisconti A; Casetta G; Aimo P; Rolle L; Greco A; Dogliotti L; Fontana D; Tizzani A
Circulating microRNAs combined with PSA for accurate and non-invasive prostate cancer detection
2019-01-01 Mello-Grand M.; Gregnanin I.; Sacchetto L.; Ostano P.; Zitella A.; Bottoni G.; Oderda M.; Marra G.; Munegato S.; Pardini B.; Naccarati A.; Gasparini M.; Gontero P.; Chiorino G.
Comparison between two commercially available chromogranin A assays in detecting neuroendocrine differentiation in prostate cancer and benign prostate hyperplasia
2007-01-01 ZITELLA A; BERRUTI A; DESTEFANIS P; MENGOZZI G; TORTA M; CERUTI C; CASETTA G; MOSCA A; GRECO A; ROLLE L; AIMO G; AROASIO E; TIZZANI A; DOGLIOTTI L; FONTANA D; GRUPPO ONCOLOGICO UROLOGICO PIEMONTESE GOUP
Effect of finasteride on the sensitivity of PSA to detect prostate cancer in rebiopsy series.
2010-01-01 Oderda M; Zitella A; Richiardi L; Tizzani A; Gontero P.
Ki-67, topoisomerase IIα and miR-221 have a limited prostate cancer risk stratification ability on a medium-term follow-up: results of a high-risk radical prostatectomy cohort
2022-01-01 Marra G.; Oderda M.; Calleris G.; Marquis A.; Peretti F.; Zitella A.; Moschini M.; Sanchez-Salas R.; Karnes R.J.; Kneitz B.; Spahn M.; Pacchioni D.; Gontero P.
Low levels of urinary psa better identify prostate cancer patients
2021-01-01 Occhipinti S.; Mengozzi G.; Oderda M.; Zitella A.; Molinaro L.; Novelli F.; Giovarelli M.; Gontero P.
New insights on occupational exposure and bladder cancer risk: a pooled analysis of two Italian case–control studies
2019-01-01 Sciannameo, Veronica; Carta, Angela; d’Errico, Angelo; Giraudo, Maria Teresa; Fasanelli, Francesca; Arici, Cecilia; Maule, Milena; Carnà, Paolo; Destefanis, Paolo; Rolle, Luigi; Gontero, Paolo; Casetta, Giovanni; Zitella, Andrea; Cucchiarale, Giuseppina; Vineis, Paolo; Porru, Stefano; Sacerdote, Carlotta; Ricceri, Fulvio
POLYMORPHISMS IN DNA REPAIR GENES MODIFY SURVIVAL OF BLADDER CANCER PATIENTS
2012-01-01 P Destefanis; C Sacerdote; F Ricceri; A Allione; G Casetta; G Cucchiarale; L Rolle; A Bosio; P Gontero; A Zitella; P Vineis; G Matullo; D Fontana
Polymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapy.
2013-01-01 Sacerdote C;Guarrera S;Ricceri F;Pardini B;Polidoro S;Allione A;Critelli R;Russo A;Andrew AS;Ye Y;Wu X;Kiemeney LA;Bosio A;Casetta G;Cucchiarale G;Destefanis P;Gontero P;Rolle L;Zitella A;Fontana D;Vineis P;Matullo G
Progression from superficial to invasive carcinoma of the bladder: genetic evidence of either clonal heterogeneous events.
2001-01-01 M. VOLANTE; A. TIZZANI; G. CASETTA; A. ZITELLA; D. PACCHIONI; G. BUSSOLATI
Prostate Cancer Detection Rate with Koelis Fusion Biopsies versus Cognitive Biopsies: A Comparative Study
2016-01-01 Oderda, Marco; Faletti, Riccardo; Battisti, Giacomo; Dalmasso, Ettore; Falcone, Marco; Marra, Giancarlo; Palazzetti, Anna; Zitella, Andrea; Bergamasco, Laura; Gandini, Giovanni; Gontero, Paolo
RNASEL R462Q is significantly associated with Prostate Cancer in the Italian population
2005-01-01 M. M. van Duist; D. Giachino; A. Zitella; P. De Stefanis; M. E. Graziano; C. Cracco; R. Scarpa; U. Ferrando; D. Fontana; A. Tizzani; M. De Marchi
Shortened telomere length and survival in bladder cancer patients
2013-01-01 Alessia Russo; Federica Modica; Simonetta Guarrera; Giovanni Fiorito; Alessandra Allione; Barbara Pardini; Rossana Critelli; Fulvio Ricceri; Andrea Bosio; Giovanni Casetta; Giuseppina Cucchiarale; Paolo Destefanis; Paolo Gontero; Luigi Rolle; Andrea Zitella; Dario Fontana; Paolo Vineis; Carlotta Sacerdote; Giuseppe Matullo
SHORTENED TELOMERE LENGTH AND SURVIVAL IN BLADDER CANCER PATIENTS
2013-01-01 Alessia Russo; Federica Modica; Simonetta Guarrera; Giovanni Fiorito; Alessandra Allione; Barbara Pardini; Rossana Critelli; Fulvio Ricceri; Andrea Bosio; Giovanni Casetta; Giuseppina Cucchiarale; Paolo Destefanis; Paolo Gontero; Luigi Rolle; Andrea Zitella; Dario Fontana; Paolo Vineis; Carlotta Sacerdote; Giuseppe Matullo
Shorter Leukocyte Telomere Length Is Independently Associated with Poor Survival in Patients with Bladder Cancer
2015-01-01 A. Russo;F. Modica;S. Guarrera;G. Fiorito;B. Pardini;C. Viberti;A. Allione;R. Critelli;A. Bosio;G. Casetta;G. Cucchiarale;P. Destefanis;P. Gontero;L. Rolle;A. Zitella;D. Fontana;B. Frea;P. Vineis;C. Sacerdote;G. Matullo
SINGLE NUCLEOTIDE POLYMORPHISMS (SNP) AND HAPLOTYPES IN PSA PROMOTER: A NEW PROMISING PROSTATE CANCER SUSCEPTIBILITY AND PROGNOSIS PREDICTOR TOOL
2011-01-01 P Gontero; A Zitella; D Giachino; E De Franco; M De Marchi; E De Filippi; F Peraldo; F Pisano; A Tizzani
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 68Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC): a prospective single-centre study in patients eligible for salvage therapy | 2020 | Deandreis D.; Guarneri A.; Ceci F.; Lillaz B.; Bartoncini S.; Oderda M.; Nicolotti D.G.; Pilati E.; Passera R.; Zitella A.; Bello M.; Parise R.; Carlevato R.; Ricardi U.; Gontero P. | |
| [Neuroendocrine bladder cancer: oncological emergency?] | 2008 | Fiorito, C; Lucca, I; Oderda, M; Mondino, P; Berta, G; Cattaneo, E A; Valentino, F; Zitella, A; Pacchioni, D | |
| A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"? | 2015 | Gontero, Paolo; Marra, Giancarlo; Soria, Francesco; Oderda, Marco; Zitella, Andrea; Baratta, Francesca; Chiorino, Giovanna; Gregnanin, Ilaria; Daniele, Lorenzo; Cattel, Luigi; Frea, Bruno; Brusa, Paola | |
| Association Study between Polymorphisms in DNA Methylation-Related Genes and Testicular Germ Cell Tumor Risk | 2022 | Grasso, Chiara; Popovic, Maja; Isaevska, Elena; Lazzarato, Fulvio; Fiano, Valentina; Zugna, Daniela; Pluta, John; Weathers, Benita; D'Andrea, Kurt; Almstrup, Kristian; Anson-Cartwright, Lynn; Bishop, D Timothy; Chanock, Stephen J; Chen, Chu; Cortessis, Victoria K; Dalgaard, Marlene D; Daneshmand, Siamak; Ferlin, Alberto; Foresta, Carlo; Frone, Megan N; Gamulin, Marija; Gietema, Jourik A; Greene, Mark H; Grotmol, Tom; Hamilton, Robert J; Haugen, Trine B; Hauser, Russ; Karlsson, Robert; Kiemeney, Lambertus A; Lessel, Davor; Lista, Patrizia; Lothe, Ragnhild A; Loveday, Chey; Meijer, Coby; Nead, Kevin T; Nsengimana, Jérémie; Skotheim, Rolf I; Turnbull, Clare; Vaughn, David J; Wiklund, Fredrik; Zheng, Tongzhang; Zitella, Andrea; Schwartz, Stephen M; McGlynn, Katherine A; Kanetsky, Peter A; Nathanson, Katherine L; Richiardi, Lorenzo | |
| Chromogranine A serum levels in patients affected by prostate cancer and benign prostate hypertrophy: comparison between two different commercial kits | 2005 | Bosio A; Berruti A; Zitella A; Mengozzi G; Destefanis P; Bisconti A; Casetta G; Aimo P; Rolle L; Greco A; Dogliotti L; Fontana D; Tizzani A | |
| Circulating microRNAs combined with PSA for accurate and non-invasive prostate cancer detection | 2019 | Mello-Grand M.; Gregnanin I.; Sacchetto L.; Ostano P.; Zitella A.; Bottoni G.; Oderda M.; Marra G.; Munegato S.; Pardini B.; Naccarati A.; Gasparini M.; Gontero P.; Chiorino G. | |
| Comparison between two commercially available chromogranin A assays in detecting neuroendocrine differentiation in prostate cancer and benign prostate hyperplasia | 2007 | ZITELLA A; BERRUTI A; DESTEFANIS P; MENGOZZI G; TORTA M; CERUTI C; CASETTA G; MOSCA A; GRECO A; ROLLE L; AIMO G; AROASIO E; TIZZANI A; DOGLIOTTI L; FONTANA D; GRUPPO ONCOLOGICO UROLOGICO PIEMONTESE GOUP | |
| Effect of finasteride on the sensitivity of PSA to detect prostate cancer in rebiopsy series. | 2010 | Oderda M; Zitella A; Richiardi L; Tizzani A; Gontero P. | |
| Ki-67, topoisomerase IIα and miR-221 have a limited prostate cancer risk stratification ability on a medium-term follow-up: results of a high-risk radical prostatectomy cohort | 2022 | Marra G.; Oderda M.; Calleris G.; Marquis A.; Peretti F.; Zitella A.; Moschini M.; Sanchez-Salas R.; Karnes R.J.; Kneitz B.; Spahn M.; Pacchioni D.; Gontero P. | |
| Low levels of urinary psa better identify prostate cancer patients | 2021 | Occhipinti S.; Mengozzi G.; Oderda M.; Zitella A.; Molinaro L.; Novelli F.; Giovarelli M.; Gontero P. | |
| New insights on occupational exposure and bladder cancer risk: a pooled analysis of two Italian case–control studies | 2019 | Sciannameo, Veronica; Carta, Angela; d’Errico, Angelo; Giraudo, Maria Teresa; Fasanelli, Francesca; Arici, Cecilia; Maule, Milena; Carnà, Paolo; Destefanis, Paolo; Rolle, Luigi; Gontero, Paolo; Casetta, Giovanni; Zitella, Andrea; Cucchiarale, Giuseppina; Vineis, Paolo; Porru, Stefano; Sacerdote, Carlotta; Ricceri, Fulvio | |
| POLYMORPHISMS IN DNA REPAIR GENES MODIFY SURVIVAL OF BLADDER CANCER PATIENTS | 2012 | P Destefanis; C Sacerdote; F Ricceri; A Allione; G Casetta; G Cucchiarale; L Rolle; A Bosio; P Gontero; A Zitella; P Vineis; G Matullo; D Fontana | |
| Polymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapy. | 2013 | Sacerdote C;Guarrera S;Ricceri F;Pardini B;Polidoro S;Allione A;Critelli R;Russo A;Andrew AS;Ye Y;Wu X;Kiemeney LA;Bosio A;Casetta G;Cucchiarale G;Destefanis P;Gontero P;Rolle L;Zitella A;Fontana D;Vineis P;Matullo G | |
| Progression from superficial to invasive carcinoma of the bladder: genetic evidence of either clonal heterogeneous events. | 2001 | M. VOLANTE; A. TIZZANI; G. CASETTA; A. ZITELLA; D. PACCHIONI; G. BUSSOLATI | |
| Prostate Cancer Detection Rate with Koelis Fusion Biopsies versus Cognitive Biopsies: A Comparative Study | 2016 | Oderda, Marco; Faletti, Riccardo; Battisti, Giacomo; Dalmasso, Ettore; Falcone, Marco; Marra, Giancarlo; Palazzetti, Anna; Zitella, Andrea; Bergamasco, Laura; Gandini, Giovanni; Gontero, Paolo | |
| RNASEL R462Q is significantly associated with Prostate Cancer in the Italian population | 2005 | M. M. van Duist; D. Giachino; A. Zitella; P. De Stefanis; M. E. Graziano; C. Cracco; R. Scarpa; U. Ferrando; D. Fontana; A. Tizzani; M. De Marchi | |
| Shortened telomere length and survival in bladder cancer patients | 2013 | Alessia Russo; Federica Modica; Simonetta Guarrera; Giovanni Fiorito; Alessandra Allione; Barbara Pardini; Rossana Critelli; Fulvio Ricceri; Andrea Bosio; Giovanni Casetta; Giuseppina Cucchiarale; Paolo Destefanis; Paolo Gontero; Luigi Rolle; Andrea Zitella; Dario Fontana; Paolo Vineis; Carlotta Sacerdote; Giuseppe Matullo | |
| SHORTENED TELOMERE LENGTH AND SURVIVAL IN BLADDER CANCER PATIENTS | 2013 | Alessia Russo; Federica Modica; Simonetta Guarrera; Giovanni Fiorito; Alessandra Allione; Barbara Pardini; Rossana Critelli; Fulvio Ricceri; Andrea Bosio; Giovanni Casetta; Giuseppina Cucchiarale; Paolo Destefanis; Paolo Gontero; Luigi Rolle; Andrea Zitella; Dario Fontana; Paolo Vineis; Carlotta Sacerdote; Giuseppe Matullo | |
| Shorter Leukocyte Telomere Length Is Independently Associated with Poor Survival in Patients with Bladder Cancer | 2015 | A. Russo;F. Modica;S. Guarrera;G. Fiorito;B. Pardini;C. Viberti;A. Allione;R. Critelli;A. Bosio;G. Casetta;G. Cucchiarale;P. Destefanis;P. Gontero;L. Rolle;A. Zitella;D. Fontana;B. Frea;P. Vineis;C. Sacerdote;G. Matullo | |
| SINGLE NUCLEOTIDE POLYMORPHISMS (SNP) AND HAPLOTYPES IN PSA PROMOTER: A NEW PROMISING PROSTATE CANCER SUSCEPTIBILITY AND PROGNOSIS PREDICTOR TOOL | 2011 | P Gontero; A Zitella; D Giachino; E De Franco; M De Marchi; E De Filippi; F Peraldo; F Pisano; A Tizzani |